Viewing nowCombinationCrejet Tablet 10/5 mg (Ezetimibe, Rosuvastatin)
Rosuvastatin Calcium Micronized 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.

MFDS item code 201506800 · Approved 2015.09.24 · Insurance code 641606150
Reduction of LDL cholesterol and increase of HDL cholesterol for the management of hypercholesterolemia (primary, mixed) and dyslipidemia, as well as prevention of atherosclerotic vascular disease risk.
This medication is used as an adjunct therapy to lower high total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol levels while increasing HDL cholesterol in patients with primary hypercholesterolemia or mixed dyslipidemia. It is particularly used to reduce the risk of atherosclerotic vascular diseases caused by hypercholesterolemia and is effective when combined with appropriate dietary therapy. Additionally, it is recommended for use when dietary and other non-pharmacological treatments are insufficient. Before treatment, it is important to identify other causes that may cause dyslipidemia, such as diabetes and hypothyroidism, and to undertake necessary treatments. During treatment, total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride levels should be monitored regularly to assess the effectiveness and safety of the therapy. This drug helps effectively control dyslipidemia and reduce the risk of cardiovascular diseases.
This medication is administered once daily regardless of meals. The dosage range is 10/5 mg to 10/20 mg per day. An initial dose of 10/5 mg is recommended. For patients requiring more significant LDL cholesterol reduction, the dosage may be adjusted. After starting treatment or adjusting the dose, lipid levels should be checked at intervals of at least 4 weeks to adjust the dosage accordingly.
This medication may pose a risk of muscle problems, so any symptoms such as muscle pain, muscle cramps, or muscle weakness should be reported to a physician immediately. Serious myopathy or rhabdomyolysis may occur; therefore, if these symptoms are severe or CPK levels significantly increase, treatment should be discontinued. Patients with poor liver function or a history of liver disease should undergo regular liver function tests, and if liver enzyme levels rise significantly, administration should be stopped. This medication should also be used with caution in patients with impaired renal function, and it should not be administered in cases of severe renal impairment. Pregnant or potentially pregnant women and nursing mothers should not use this drug, and fertile women should use effective contraception during treatment. Individuals with alcohol dependence, liver abnormalities, elderly patients, and hypothyroid patients, who have a higher risk of muscle problems, should consult a physician before administration. There may be interactions with other drugs; therefore, if there are any other medications being taken, they should be disclosed, particularly avoiding combination with fibrate class drugs. This medication contains lactose, so patients with lactose intolerance should not take it. Caution is advised as dizziness and other symptoms may occur during driving or operating machinery. Regular blood tests, liver function tests, and muscle-related tests during treatment are important to check for abnormalities.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain of mucous membranes in mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough + fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination problems.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air and moisture, and it is best to keep it at temperatures between 1 and 30 degrees Celsius. Storing it in this manner will help maintain the medication's effectiveness for a long time.
Pink, rectangular, film-coated tablet
30 tablets (10 tablets/ PTP x 3), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium Micronized 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationRosuvastatin Calcium Micronized 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium Micronized 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium Micronized 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.